TELA Bio, Inc. (TELA)

TELA Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	114	162	220	186	217	148
Market Cap Growth	-31.65%	-26.42%	18.68%	-14.47%	46.96%	-
Enterprise Value	117	156	218	173	173	123
PE Ratio	-	-3.47	-4.97	-5.58	-7.54	-4.89
PS Ratio	1.80	2.77	5.32	6.30	11.92	9.56
PB Ratio	7.90	8.59	15.40	9.24	4.43	4.77
P/FCF Ratio	-3.14	-3.91	-5.29	-5.98	-8.82	-5.74
P/OCF Ratio	-3.20	-3.97	-5.41	-6.10	-8.88	-5.79
EV/Sales Ratio	1.85	2.66	5.27	5.88	9.53	7.99
EV/EBITDA Ratio	-4.19	-3.83	-5.59	-5.94	-7.02	-6.77
EV/EBIT Ratio	-4.09	-3.76	-5.42	-5.84	-6.88	-6.56
EV/FCF Ratio	-3.22	-3.75	-5.24	-5.58	-7.05	-4.80
Debt / Equity Ratio	2.83	2.15	2.79	1.57	0.63	0.98
Debt / EBITDA Ratio	-1.19	-1.00	-1.02	-1.08	-1.25	-1.66
Debt / FCF Ratio	-0.91	-0.98	-0.96	-1.01	-1.25	-1.18
Quick Ratio	3.12	3.34	3.92	4.55	11.67	8.55
Current Ratio	4.13	4.23	5.04	5.58	12.60	9.58
Asset Turnover	0.76	0.73	0.65	0.42	0.22	0.33
Interest Coverage	-6.59	-7.93	-9.93	-8.25	-7.08	-5.21
Return on Equity (ROE)	-155.30%	-201.60%	-384.30%	-106.90%	-59.70%	56.50%
Return on Assets (ROA)	-48.60%	-58.60%	-69.70%	-47.00%	-34.40%	-63.50%
Return on Capital (ROIC)	-82.16%	-74.21%	-71.94%	-57.09%	-31.65%	-31.31%
Earnings Yield	-35.45%	-28.78%	-20.10%	-17.92%	-13.27%	-20.45%
FCF Yield	-39.11%	-25.57%	-18.89%	-16.73%	-11.34%	-17.41%
Buyback Yield / Dilution	-28.11%	-40.58%	-12.40%	-11.90%	-632.24%	-498.81%
Total Shareholder Return	-28.11%	-40.58%	-12.40%	-11.90%	-632.24%	-498.81%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).